Abstract
Malignant pleural effusion represents advanced disease. Management is determined by the patient’s performance status, symptoms and degree of lung re expansion after pleural fluid drainage. The goal of management is control of patient symptoms, with minimum morbidity and maximum patient independence. Pleural fluid evacuation and long term palliation can be achieved by either chemical pleurodesis or patient controlled drainage with a tunneled pleural catheter. Thoughtful patient evaluation is critical to choosing the appropriate palliative option for each individual with malignant pleural effusion.
Keywords: Malignant effusions, pleurodesis, thoracoscopy, tunneled pleural catheter, Decortications, neoplasm, PLEURAL LINING, mesothelial layer, endothelial, fibroblasts, pleural fluid.
Current Respiratory Medicine Reviews
Title:Malignant Pleural Effusion Evaluation and Management
Volume: 8 Issue: 4
Author(s): Jed A. Gorden and Joelle Thirsk Fathi
Affiliation:
Keywords: Malignant effusions, pleurodesis, thoracoscopy, tunneled pleural catheter, Decortications, neoplasm, PLEURAL LINING, mesothelial layer, endothelial, fibroblasts, pleural fluid.
Abstract: Malignant pleural effusion represents advanced disease. Management is determined by the patient’s performance status, symptoms and degree of lung re expansion after pleural fluid drainage. The goal of management is control of patient symptoms, with minimum morbidity and maximum patient independence. Pleural fluid evacuation and long term palliation can be achieved by either chemical pleurodesis or patient controlled drainage with a tunneled pleural catheter. Thoughtful patient evaluation is critical to choosing the appropriate palliative option for each individual with malignant pleural effusion.
Export Options
About this article
Cite this article as:
A. Gorden Jed and Thirsk Fathi Joelle, Malignant Pleural Effusion Evaluation and Management, Current Respiratory Medicine Reviews 2012; 8 (4) . https://dx.doi.org/10.2174/157339812802652170
DOI https://dx.doi.org/10.2174/157339812802652170 |
Print ISSN 1573-398X |
Publisher Name Bentham Science Publisher |
Online ISSN 1875-6387 |
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
Related Articles
-
The Molecular Basis of Herpesviruses as Oncolytic Agents
Current Pharmaceutical Biotechnology MATra - Magnet Assisted Transfection: Combining Nanotechnology and Magnetic Forces to Improve Intracellular Delivery of Nucleic Acids
Current Pharmaceutical Biotechnology Synthesis and Altered Biodistribution of 99mTc Labeled Vincristine in Animal Model
Current Medical Imaging MicroRNAs and Targeted Therapies in Non-small Cell Lung Cancer: Minireview
Anti-Cancer Agents in Medicinal Chemistry Pharmacokinetics of Biotech Drugs: Peptides, Proteins and Monoclonal Antibodies
Current Drug Metabolism Effect of HAART on Salivary Composition and Oxidative Profile in HIVInfected Patients
Current HIV Research Strategies to Improve the Killing of Tumors Using Temozolomide: Targeting the DNA Repair Protein MGMT
Current Medicinal Chemistry The Role of Fibroblast Growth Factors in Tumor Growth
Current Cancer Drug Targets HGF and RhoGTPases in Cancer Cell Motility
Current Signal Transduction Therapy Strategies for Targeting the Multidrug Resistance-1 (MDR1)/P-gp Transporter in Human Malignancies
Current Cancer Drug Targets Clinical Development of MET Targeted Therapy For Human Cancer
Current Cancer Therapy Reviews Anti-Proliferative, Anti-Inflammatory, Anti-Ulcerogenic and Wound Healing Properties of Chitosan
Current Bioactive Compounds Looking at Drug Resistance Mechanisms for Microtubule Interacting Drugs: Does TUBB3 Work?
Current Cancer Drug Targets Clinical Application of Sorafenib for Treating Hepatocellular Carcinoma and Beyond
Clinical Cancer Drugs Analysis of the Molecular Determinants of the Response of Chronic Myelogenous Leukaemia to Tyrosine Kinase Inhibitors
Current Pharmacogenomics Staurosporine Analogues from Microbial and Synthetic Sources and Their Biological Activities
Current Medicinal Chemistry Tumour-Specific Uptake of Anti-Cancer Drugs: The Future is Here
Current Drug Metabolism Three-Dimensional Ultrasound in Soft Tissue Tumor Imaging
Current Medical Imaging Hypoxia-Inducible Factor-1 (HIF-1): A Potential Target for Intervention in Ocular Neovascular Diseases
Current Drug Targets The Role of C-Reactive Protein in Atherosclerotic Cardiovascular Disease: An Overview
Current Vascular Pharmacology